During the past decade, Summit Cancer Care-Memorial conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 34 clinical trials were completed, i.e. on average, 68% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 25 clinical trials were completed. i.e. 208.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Summit Cancer Care-Memorial" #1 sponsor was "National Cancer Institute (NCI)" with 19 trials, followed by "SWOG Cancer Research Network" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "Bristol-Myers Squibb" with 6 trials sponsored and "Eli Lilly and Company" with 6 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Summit Cancer Care-Memorial" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Bayer" with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Summit Cancer Care-Memorial" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Breast Cancer" (4 trials), "Multiple Myeloma" (4 trials) and "Recurrent Ovarian Carcinoma" (4 trials). Many other conditions were trialed in "Summit Cancer Care-Memorial" in a lesser frequency.

Most popular intervention types in "Summit Cancer Care-Memorial" are "Drug" (56 trials), "Other" (35 trials), "Biological" (22 trials), "Procedure" (10 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (22 trials), "Quality-of-Life Assessment" (12 trials), "Docetaxel" (10 trials), "Nivolumab" (10 trials) and "Bevacizumab" (7 trials). Other intervention names were less common.

The vast majority of trials in "Summit Cancer Care-Memorial" are 54 trials for "All" genders, 16 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Summit Cancer Care-Memorial". undefined are not yet recruiting, 15 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Summit Cancer Care-Memorial, 2 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Summit Cancer Care-Memorial, 1 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".

Summit Cancer Care-Memorial has several departments that took part in Clinical trials: "Summit Cancer Care-Candler" - 39 trials